jointly by the National Marrow Donor Program®/Be The
Match® and the Aplastic Anemia and MDS
Release date: June 8, 2017
Expiration date: June 8, 2018
Aplastic anemia is a rare disease in which the bone marrow stops producing enough blood cells.1 Any blood cells the marrow does make are completely normal, but there are simply not enough of them to serve the body's needs.2 In the United States, about 600-900 people are diagnosed each year.3 Aplastic anemia can be moderate, severe or very severe, but with prompt and proper care most patients can be successfully treated.
In this free continuing education webinar a physician and social worker will present current research and case examples to illustrate treatment options and common experiences for patients with aplastic anemia and their families. The goal of this activity is to ensure that members of a multidisciplinary team have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with severe aplastic anemia. Attendees are encouraged to submit questions for a Q&A discussion.
Hematology, oncology and BMT nurses; hematology, oncology and BMT social workers at intermediate to advanced levels of practice, experience and licensure; transplant center coordinators; payer case managers and other allied health professionals.
CE/CME APPROVED FOR: Hematology, oncology and BMT nurses; hematology, oncology and BMT social workers at intermediate to advanced levels of practice, experience and licensure; transplant center coordinators; payer case managers, gerontology advanced practice nursesand other allied health professionals.
- Identify presenting symptoms of severe aplastic anemia and tests used to classify the diagnosis.
- Compare and contrast patient outcomes with immunosuppressive therapy and/or BMT.
- Review indications for referral for BMT.
- Summarize psychosocial assessment considerations: education for related donors including minors and caregiver screening.
- List programs and resources to support patients with severe aplastic anemia and their caregivers.
David A Margolis, MD
Program Director, Bone Marrow Transplant, Children's Hospital of Wisconsin and Professor, The Medical College of Wisconsin
Sheila Dodds, MSW
Pediatric Social Worker, Bone Marrow Transplant Program, Children’s Hospital of Wisconsin